Triangle Securities Wealth Management Bristol Myers Squibb CO Transaction History
Triangle Securities Wealth Management
- $412 Million
- Q3 2025
A detailed history of Triangle Securities Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Triangle Securities Wealth Management holds 16,105 shares of BMY stock, worth $717,316. This represents 0.18% of its overall portfolio holdings.
Number of Shares
16,105
Previous 15,628
3.05%
Holding current value
$717,316
Previous $723,000
0.41%
% of portfolio
0.18%
Previous 0.19%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...